Product Information
PREMARIN VAGINAL CREAM-APPL is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $15.0744 per GM under NDC 00046087221. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982.
Strength
.625 mg/g
NDC
00046087221
Classification
Brand
Dosage Form
CREAM
Route
VAGINAL
Effective Date
9/23/2026
Active Ingredients
ESTROGENS, CONJUGATEDApproval Type
New Drug (NDA)
FDA Application
NDA020216FDA Approved
Before 1982
On Market Since
11/1/1978
Pharmacological Classes
Price Statistics
The NADAC for PREMARIN VAGINAL CREAM-APPL has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 144.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.0744 per GM |
|---|---|
| All-time high | $15.0991 (May 13, 2026) |
| All-time low | $6.1733 (Nov 28, 2013) |
| 52-week high | $15.0991 |
| 52-week low | $14.7017 |
| Median price | $12.5386 |
| Average price | $11.9241 |
| Largest weekly change | +9.4% (Jan 6, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the conjugated estrogens market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
conjugated estrogens market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PREMARIN VAGINAL CREAM-APPL?
The current National Average Drug Acquisition Cost (NADAC) for PREMARIN VAGINAL CREAM-APPL, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $15.0744 per GM (NDC 00046087221), effective Sep 30, 2026.
How has the price of PREMARIN VAGINAL CREAM-APPL changed over time?
Over the history we have for it, the NADAC for PREMARIN VAGINAL CREAM-APPL has risen 144.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREMARIN VAGINAL CREAM-APPL?
Since Nov 28, 2013, the NADAC for PREMARIN VAGINAL CREAM-APPL has ranged from a low of $6.1733 (Nov 28, 2013) to a high of $15.0991 (May 13, 2026), with a median of $12.5386 per GM.
Are there cheaper alternatives to PREMARIN VAGINAL CREAM-APPL?
No other NADAC-published product currently shares the active ingredient and strength of PREMARIN VAGINAL CREAM-APPL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PREMARIN VAGINAL CREAM-APPL?
PREMARIN VAGINAL CREAM-APPL (NDC 00046087221) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.